Reply to the letter by Takeshi Yamada et al. concerning 'Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?'

Zhou Jun; Peng Zhi; Shen Lin

首页> 外文期刊>Journal of gastroenterology >Reply to the letter by Takeshi Yamada et al. concerning 'Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?'

【24h】

Reply to the letter by Takeshi Yamada et al. concerning 'Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?'

机译：回复山田武等人的信。关于“血清HER2 ECD是否是晚期胃癌对曲妥珠单抗反应的预测性生物标志物？”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of gastroenterology》 |2016年第5期|共1页
作者
Zhou Jun; Peng Zhi; Shen Lin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Reply to the letter by Takeshi Yamada et al. concerning "Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?" [J] . Zhou Jun, Peng Zhi, Shen Lin Journal of gastroenterology . 2016,第5期

机译：回复山田武等人的信。关于“血清HER2 ECD是否是晚期胃癌对曲妥珠单抗反应的预测性生物标志物？”
2. Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy (vol 50, pg 955, 2015) [J] . Zhou Jun, Peng Zhi, Liu Yi, Journal of gastroenterology . 2016,第5期

机译：曲妥珠单抗联合化疗治疗HER2阳性晚期胃癌患者血清HER2 ECD的预测价值（第50卷，第955页，2015年）
3. Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy [J] . DepartmentofGastrointestinalOncologyKeyLaboratoryofCarcinogenesisandTranslationalResearch, TranslationalMedicineCenterLaboratoryofOncology Journal of gastroenterology . 2015,第9期

机译：曲妥珠单抗联合化疗治疗HER2阳性晚期胃癌患者血清HER2 ECD的预测价值
4. Combination of Novel HER2 Targeting Antibody 1A12 with Trastuzumab Shows Synergistic Antitumor Activity in HER2 Positive Gastric Cancer [C] . Kyu-Tae Kim, Jong-Seo Lee, Ki-Hyun Kim, PEGS . 2015

机译：具有曲妥珠单抗的新型HER2靶向抗体1a12的组合在HER2阳性胃癌中显示了协同抗肿瘤活性
5. Gut Microbiota and Trastuzumab Response in HER2-Positive Breast Cancer [D] . Di Modica, Martina. 2020

机译：肠道微生物群和胸瘤反应在Her2阳性乳腺癌中
6. Reply to the Letter to the Editor by C. Nicolazzo et al.: Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy [O] . Angela Alama, Simona Coco, Irene Vanni, 2017

机译：回复C. Nicolazzo等人给编辑的信：循环无细胞DNA和循环肿瘤细胞作为一线化疗治疗的晚期非小细胞肺癌患者的预后和预测生物标志物
7. Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy” [O] . Angela Alama, Simona Coco, Irene Vanni, 2017

机译：回复C. Nicolazzo等人给编辑的信：“循环无细胞DNa和循环肿瘤细胞作为一线化疗治疗的晚期非小细胞肺癌患者的预后和预测生物标志物”

Reply to the letter by Takeshi Yamada et al. concerning 'Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?'

著录项

相似文献

相关主题

期刊订阅